Check out work from our group presented at
#AHA25 @American_Heart scientific sessions this weekend:
🔶 Polygenic Risk Score-Based Enrichment of Primary Prevention Cohorts for Atherosclerotic Cardiovascular Disease Trials
@OzanUnluMD (Award Finalist)
Sat Nov 8 10:15AM | 278-282
🔶 Development and Validation of a Clinical Polygenic Risk Report for Cardiometabolic Disease in a US-Based health System
@AniruddhPatelMD (Award Finalist)
Led by
@pnatarajanmd group
Sat Nov 8 10:45 | 278-282
🔶 Multidomain Risk Profiles and Disease Progression Across Atherosclerotic Vascular Bes
@KelvinS_MD (Award Finalist)
Sat Nov 8 10:45 | 265-268
🔶 Predictive Utility of Genomics, Inflammation, Cholesterol, and Lipoprotein(a) in Assessing Coronary Artery Disease Risk Across Age and Sex
@rayshafarah
Sat Nov 8 3:15 | GE.MDP.03
🔶Polygenic-Risk Based Detection and Treatment of Subclinical Coronary Atherosclerosis in the PROACT Clinical Trials
@RoukozAKaram
Sat Nov 8 3:43 | GE.MDP.02
🔶Integrating Polygenic and Clinical Risk Factors Enhances Stability of Coronary Artery Disease Risk Prediction
Dr. Akash Kumar
@myomeinc sponsored research
Sat Nov 8 3:50 | GE-MDP.03
♦️ CV-PRS: Clinical Trials and Drug Development
@aklfahed
Sun Nov 9 3:30 | 203-205
🔶Three-year Outcomes after Deceased Cardiac Donor Heart Transplantation
Dr. Brian Huang
@mghmedres
Mon Nov 10 12:36 | HF.MDP.12
🔶Interactions Between Polygenic Risk Scores and Social Determinants of Health in Coronary Artery Disease
@carlsadek @Harvard premed
Mon Nov 10 2:13 | GE.MDP.07
More about our group at
fahedlab.com
@MGHHeartHealth @broadinstitute @PinakShahMD @patrick_ellinor